Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Commentary

Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?

Stanley Nattel
CMAJ September 28, 2004 171 (7) 752-753; DOI: https://doi.org/10.1503/cmaj.1040853
Stanley Nattel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

Article Information

vol. 171 no. 7 752-753
DOI 
https://doi.org/10.1503/cmaj.1040853
PubMed 
15451839
History 
  • Published online September 27, 2004.
Copyright & Usage 
© 2004 Canadian Medical Association or its licensors

Author Information

  1. Stanley Nattel
  1. Dr. Nattel is Senior Scientist at the Research Center, Montreal Heart Institute, and Paul-David Chair in Cardiovascular Electrophysiology and Professor of Medicine at the University of Montreal, Montréal, Que. He is supported by the Canadian Institutes of Health Research, Quebec Heart Foundation and Paul-David Chair in Cardiovascular Electrophysiology, University of Montreal.
  1. Correspondence to:
    Dr. Stanley Nattel, Montreal Heart Institute Research Center, 5000 Belanger St. E., Montréal QC H1T 1C8; fax 514 376-1355; Stanley.nattelicm-mhi.org

Statistics from Altmetric.com

Usage statistics: September 2004 to January 2021

AbstractFullPdf
Sep 2004113984
Oct 20045400187
Nov 2004619597
Dec 2004713963
Jan 2005815872
Feb 200539438
Mar 2005412931
Apr 200517338
May 200515634
Jun 200536122
Jul 200505021
Aug 200536644
Sep 200506816
Oct 200505934
Nov 200507529
Dec 200516713
Jan 200902313
Feb 20090238
Mar 200907615
Apr 200906015
May 200903123
Jun 20090184
Jul 20090124
Aug 200902225
Sep 200903118
Oct 200903110
Nov 200904611
Dec 20090246
Jan 201002812
Feb 20100223
Mar 20100229
Apr 20100184
May 20100336
Jun 20100307
Jul 20100247
Aug 20100375
Sep 201003514
Oct 20100318
Nov 201002014
Dec 20100154
Jan 20110156
Feb 2011055
Mar 20110124
Apr 2011093
May 20110107
Jun 201101013
Jul 20110108
Aug 201101613
Sep 20110357
Oct 20110198
Nov 20110326
Dec 201104613
Jan 20120243
Feb 20120439
Mar 201203011
Apr 20120257
May 20120384
Jun 20120183
Jul 201201815
Aug 201202311
Sep 20120243
Oct 20120227
Nov 20120236
Dec 20120184
Jan 201305611
Feb 20130195
Mar 20130144
Apr 201303010
May 201301710
Jun 20130110
Jul 2013053
Aug 20130125
Sep 2013046
Oct 20130129
Nov 2013071
Dec 2013020
Jan 2014063
Feb 2014041
Mar 2014062
Apr 2014055
May 2014094
Jun 2014022
Jul 2014075
Aug 2014095
Sep 20140115
Oct 2014095
Nov 2014054
Dec 20140133
Jan 2015057
Feb 2015060
Mar 2015065
Apr 2015021
May 20150114
Jun 2015007
Jul 2015031
Aug 2015073
Sep 2015032
Oct 2015080
Nov 2015090
Dec 20150223
Jan 20160256
Feb 20160115
Mar 20160312
Apr 2016087
May 2016055
Jun 20160172
Jul 20160122
Aug 2016098
Sep 20160196
Oct 20160115
Nov 20160138
Dec 20160100
Jan 20170101
Feb 20170111
Mar 20170111
Apr 20170104
May 2017050
Jun 20170110
Jul 2017070
Aug 2017095
Sep 2017092
Oct 2017092
Nov 20170103
Dec 20170504
Jan 20180711
Feb 20180302
Mar 20180280
Apr 20180321
May 20180450
Jun 20180341
Jul 20180332
Aug 20180110
Sep 20180153
Oct 20180192
Nov 20180242
Dec 20180252
Jan 20190144
Feb 20190153
Mar 2019053
Apr 2019093
May 2019042
Jun 2019032
Jul 2019066
Aug 2019032
Sep 2019063
Oct 20190133
Nov 2019043
Dec 2019071
Jan 2020092
Feb 2020042
Mar 2020001
Apr 2020091
May 2020032
Jun 2020023
Jul 2020062
Aug 2020015
Sep 20200194
Oct 20200224
Nov 2020082
Dec 20200127
Jan 20210128
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 171 (7)
CMAJ
Vol. 171, Issue 7
28 Sep 2004
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?
Stanley Nattel
CMAJ Sep 2004, 171 (7) 752-753; DOI: 10.1503/cmaj.1040853

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Antiarrhythmic drugs for atrial fibrillation: Do we need better use, better drugs or a randomized trial of ablation as primary therapy?
Stanley Nattel
CMAJ Sep 2004, 171 (7) 752-753; DOI: 10.1503/cmaj.1040853
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • Highlights of this issue
  • Limitations to antiarrhythmic drug use in patients with atrial fibrillation
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A “No More Waves” strategy for COVID-19 in Canada
  • The case for relaxing no-visitor policies in hospitals during the ongoing COVID-19 pandemic
  • Transforming race-based health research in Canada
Show more Commentary

Similar Articles

Collections

  • Topics
    • Cardiology: arrhythmias

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire